Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Rectal Neoplasms × Aspirin × Clear all

Phase

Status

Sponsor Class

OTHER 2 NIH 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Rectal Neoplasms 1 Neoplasm Metastasis 1 Lynch syndrome I (site-specific colonic cancer) 1 Breast Neoplasms 1

Interventions

Capecitabine 7 Fluorouracil 6 Leucovorin 5 Radiotherapy 4 Oxaliplatin 4 Laparoscopy 4 XELOX 3 Cetuximab 3 Irinotecan 2 Folfox protocol 2 Drug Therapy 2 Chemoradiotherapy 2 selinexor 1 citric acid, ispaghula husk, sodium bicarbonate drug combination 1 capecitabine-irinotecan combination 1 Vitamin D Response Element 1 Vi-siblin 1 Transanal Endoscopic Microsurgery 1 Robotics 1 Robotic Surgical Procedures 1 Psyllium 1 Polyethylene Glycols 1 N-hydroxy-4-acetylaminostilbene 1 Metronidazole 1 Liver Extracts 1 Immunohistochemistry 1 Frozen Sections 1 Filgrastim 1 Erythromycin 1 Endoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03170115 2020-12-17

ICAR

Instituto Nacional de Cancer, Brazil

Phase 2 Terminated

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡